OESOPHAGEAL
CARCINOMA
ANATOMY
• Blood supply
• -Cervical-inferior thyroid artery
• -Thoracic 4-6 aortic esophageal
arteries and branches of left
bronchial artery
• -Abdominal-Left gastric and
inferior phrenic artery
25cm hollow structure
extending from cricopharynx to
gastroesophageal junction(C7-
T10)
4 constriction
-at cricopharyngeal junction
-crossed by aortic arch
-crossed by left bronchus
-pierces the diaphragm
INTRODUCTION
• 6th most common cause of cancer in the world
• Majority of oesophageal carcinoma are squamous cell carcinoma, worldwide
• Western countries predominant are adenocarcinoma
-?mainly due to smoking , alcohol and Barrett’s oesophagus
• Poor prognosis?
-more lymph vessel are present in submucosa -spread is faster
-lymph flow in submucosal plexus runs in longitudinal direction-so primary tumour can extend for
considerable length both superiorly and inferiorly
-cervical oesophagus –has direct spread to regional lymph nodes, less lymphatics in submucosa –
prognosis better
PATHOLOGY
Squamous cell carcinoma Adenocarcinoma
2/3rd oesophagus Lower 1/3 (majority near gastroesophageal
junction)
common Rising in trend
Less common malignant oesophageal carcinoma :
-small cell carcinoma
-Melanoma
-leiomysarcoma, lymphoma
-oesophageal involvement by other metastatic tumours
AETIOPATHOGENESIS
• Precancerous/predisposing conditions
-achalasia cardia
-Barrett’s oesophagus
-corrosive stricture
-plummer vinson syndrome
-familial keratosis plantaris/palmaris(tylosis)
• Carcinogens
-tobacco, smoking, alcohol abuse
-HPV infection
-Dietary carcinogens(elevated nitrates in drinking water,food containing
fungi geotrichum candidum)
SQUAMOUS CELL
CARCINOMA
smoking.
• Alcohol: Chronic alcohol use, especially in combination with
smoking
• Gender: In western countries, the risk for men is 3 to 4 times
greater than that for women.
• Age: Risk increases with age. Approximately 75% of people
with esophageal cancer are diagnosed between 55 and 85 years
of age.
• Occupational exposures: solvents or chemical fumes (e.g., dry
cleaning chemicals).
• Human papillomavirus infection (HPV)
• Other medical conditions:
• Achalasia (a rare disorder in which the lower oesophageal
sphincter does not relax properly to allow food to pass
through);
• tylosis (a rare inherited disease linked to a genetic mutation
thought to be responsible for some esophageal cancers),
• esophageal webs (abnormal protrusions of tissue into the
esophagus that interfere with swallowing)
ADENOCARCINOMA
• Gastroesophageal reflux disease (GERD)
• Barrett’s esophagus
• Obesity: Obesity may exacerbate GERD and
Barrett’s, perhaps because it creates greater
pressure on the abdomen, which in turn,
may result in a higher frequency of GERD.
• Gender: Gender appears to be a
contributing factor, with incidence rates in
men 6 to 8 times greater than those in
women
MODE OF
SPREAD
• Direct invasion to surrounding
structure like
aorta,trachea/bronchus and
longitudinally via submucosal
lymphatic channels
• Lymph node(common )
-?lymphstics in oesophagus located in
submucosa vs rest of Gastrointestinal
tract where they are located beneath
muscularis propria
• Hematogenous spread:
-liver lungs brain bone
CLINICAL FEATURES
Local tumour effect -progressive dysphagia(solid to liquid)
-odynophagia
-loss of appetite, loss of weight
-upper GI bleed
-cough regurgitation, vomiting
Invasion of surrounding
structure
-hoarseness of voice (recurrent laryngeal nerve )
-horner’s syndrome (invasion of sympathetic chain in cervical
region causing ptosis, miosis, anhidrosis on the same side of
and enopthalmos )
-trachea-stridor
-perforation into pleural cavity-emphyema
-back pain-celiac axis node involment
Distant metastasis -hypercalcaemia (paraneoplasic syndrome in SCC)
DIAGNOSIS
• Medical history & physical examination
• Blood tests: FBC to detect anemia,
liver function tests to detect liver metastasis.
• Imaging tests: A barium swallow
Esophagoscopy (upper endoscopy)
Endoscopic biopsy
If these test results are inconclusive and suspicion of cancer still exists, endoscopic
ultrasound (EUS), with or without fine needle aspiration (FNA) biopsy may be used
Endoscopic ultrasound (EUS): EUS combines endoscopy and ultrasound to obtain
images of the esophagus.
EUS guided FNA: EUS can be used to guide the placement of a biopsy needle through
which tissue samples are extracted.
FOR STAGING
• POSITRON EMISSION AND COMPUTED TOMOGRAPHY
-CT is more sensitive than PET for evaluating local-regional lesions
- PET, however, is superior to CT for detecting distant metastatic sites
• EUS-compared to CT more reliable to evaluate extent of tumour into oesophageal
• Bronchoscopy-to rule out fistula in midesophageal lesion
Staging
SURGERY- ESOPHAGECTOMY
surgically removing all or part of the esophagus, as well as any tissue (including lymph nodes)
that may contain cancer.
To replace the esophagus, the stomach is pulled into the chest and surgically joined to any
remaining part of the esophagus.
Alternative oesophageal replacement:
-colon
-jejenum
Complications:
Early:
-Respiratory complications due to thoracotomy
-anastomotic leakage
-chylothorax
-injury to recurrent laryngeal nerve
Late:
Benign anastomotic stricture
(higher with cervical then with intrathoracic anastamosis)
TECHNIQUES OF ESOPHAGECTOMY
• Modified Ivor Lewis
-right thoracotomy and laparotomy->intrathoracic anastomosis
-resected affected esophagus, 5cm margin proximally and distal lesser curvature of
stomach
-nodal dissection include paraesophageal, subcarinal, perigastric , gastric artery region
and celiac nodes
• McKeown(3 field esophagectomy)
-right thoracotomy , upper midline laparotomy and left sided transverse neck incision
• Transhiatal esophagectomy
-upper midline laparotomy and left sided neck but has incomplete lymphadenectomy
LYMPHADENECTOMY
• 1 field –clear Lymph nodes in one area either cervical/thoracic/abdominal
• 2-field-(thoracic +abdomen)
• 3 field
For squamous cell carcinoma-usually 3 field lymphadenectomy done (as it is more
common in uppr and middle position of oesophagus)
Adenocarcinoma-usually 2 field lymphadenectomy (more common in lower esophagus)
• Neoadjuvant therapy
-with preoperative chemotherapy/chemoradiotherapy-enhance local control
and resectibility
• Radiotherapy
For attempted cure and palliation of SCC oesophageal carcinoma-if not
suitable for resection
• Palliative treatment-to relieve obstruction/mitigate dysphagia
a)Radiotherapy and chemotherapy-adenocarcinoma less responsive
b)Intraluminal prostheses-rigid tube/expanding stents
-Potential complication:
perforation , erosion
migration of the stent/obstruction
c)Endoscopic laser technique
•THANK
YOU

Esophageal carcinoma

  • 1.
  • 2.
    ANATOMY • Blood supply •-Cervical-inferior thyroid artery • -Thoracic 4-6 aortic esophageal arteries and branches of left bronchial artery • -Abdominal-Left gastric and inferior phrenic artery 25cm hollow structure extending from cricopharynx to gastroesophageal junction(C7- T10) 4 constriction -at cricopharyngeal junction -crossed by aortic arch -crossed by left bronchus -pierces the diaphragm
  • 3.
    INTRODUCTION • 6th mostcommon cause of cancer in the world • Majority of oesophageal carcinoma are squamous cell carcinoma, worldwide • Western countries predominant are adenocarcinoma -?mainly due to smoking , alcohol and Barrett’s oesophagus • Poor prognosis? -more lymph vessel are present in submucosa -spread is faster -lymph flow in submucosal plexus runs in longitudinal direction-so primary tumour can extend for considerable length both superiorly and inferiorly -cervical oesophagus –has direct spread to regional lymph nodes, less lymphatics in submucosa – prognosis better
  • 4.
    PATHOLOGY Squamous cell carcinomaAdenocarcinoma 2/3rd oesophagus Lower 1/3 (majority near gastroesophageal junction) common Rising in trend Less common malignant oesophageal carcinoma : -small cell carcinoma -Melanoma -leiomysarcoma, lymphoma -oesophageal involvement by other metastatic tumours
  • 5.
    AETIOPATHOGENESIS • Precancerous/predisposing conditions -achalasiacardia -Barrett’s oesophagus -corrosive stricture -plummer vinson syndrome -familial keratosis plantaris/palmaris(tylosis) • Carcinogens -tobacco, smoking, alcohol abuse -HPV infection -Dietary carcinogens(elevated nitrates in drinking water,food containing fungi geotrichum candidum)
  • 6.
    SQUAMOUS CELL CARCINOMA smoking. • Alcohol:Chronic alcohol use, especially in combination with smoking • Gender: In western countries, the risk for men is 3 to 4 times greater than that for women. • Age: Risk increases with age. Approximately 75% of people with esophageal cancer are diagnosed between 55 and 85 years of age. • Occupational exposures: solvents or chemical fumes (e.g., dry cleaning chemicals). • Human papillomavirus infection (HPV) • Other medical conditions: • Achalasia (a rare disorder in which the lower oesophageal sphincter does not relax properly to allow food to pass through); • tylosis (a rare inherited disease linked to a genetic mutation thought to be responsible for some esophageal cancers), • esophageal webs (abnormal protrusions of tissue into the esophagus that interfere with swallowing)
  • 7.
    ADENOCARCINOMA • Gastroesophageal refluxdisease (GERD) • Barrett’s esophagus • Obesity: Obesity may exacerbate GERD and Barrett’s, perhaps because it creates greater pressure on the abdomen, which in turn, may result in a higher frequency of GERD. • Gender: Gender appears to be a contributing factor, with incidence rates in men 6 to 8 times greater than those in women
  • 8.
    MODE OF SPREAD • Directinvasion to surrounding structure like aorta,trachea/bronchus and longitudinally via submucosal lymphatic channels • Lymph node(common ) -?lymphstics in oesophagus located in submucosa vs rest of Gastrointestinal tract where they are located beneath muscularis propria • Hematogenous spread: -liver lungs brain bone
  • 9.
    CLINICAL FEATURES Local tumoureffect -progressive dysphagia(solid to liquid) -odynophagia -loss of appetite, loss of weight -upper GI bleed -cough regurgitation, vomiting Invasion of surrounding structure -hoarseness of voice (recurrent laryngeal nerve ) -horner’s syndrome (invasion of sympathetic chain in cervical region causing ptosis, miosis, anhidrosis on the same side of and enopthalmos ) -trachea-stridor -perforation into pleural cavity-emphyema -back pain-celiac axis node involment Distant metastasis -hypercalcaemia (paraneoplasic syndrome in SCC)
  • 10.
    DIAGNOSIS • Medical history& physical examination • Blood tests: FBC to detect anemia, liver function tests to detect liver metastasis. • Imaging tests: A barium swallow Esophagoscopy (upper endoscopy) Endoscopic biopsy If these test results are inconclusive and suspicion of cancer still exists, endoscopic ultrasound (EUS), with or without fine needle aspiration (FNA) biopsy may be used Endoscopic ultrasound (EUS): EUS combines endoscopy and ultrasound to obtain images of the esophagus. EUS guided FNA: EUS can be used to guide the placement of a biopsy needle through which tissue samples are extracted.
  • 11.
    FOR STAGING • POSITRONEMISSION AND COMPUTED TOMOGRAPHY -CT is more sensitive than PET for evaluating local-regional lesions - PET, however, is superior to CT for detecting distant metastatic sites • EUS-compared to CT more reliable to evaluate extent of tumour into oesophageal • Bronchoscopy-to rule out fistula in midesophageal lesion
  • 12.
  • 16.
    SURGERY- ESOPHAGECTOMY surgically removingall or part of the esophagus, as well as any tissue (including lymph nodes) that may contain cancer. To replace the esophagus, the stomach is pulled into the chest and surgically joined to any remaining part of the esophagus. Alternative oesophageal replacement: -colon -jejenum Complications: Early: -Respiratory complications due to thoracotomy -anastomotic leakage -chylothorax -injury to recurrent laryngeal nerve Late: Benign anastomotic stricture (higher with cervical then with intrathoracic anastamosis)
  • 17.
    TECHNIQUES OF ESOPHAGECTOMY •Modified Ivor Lewis -right thoracotomy and laparotomy->intrathoracic anastomosis -resected affected esophagus, 5cm margin proximally and distal lesser curvature of stomach -nodal dissection include paraesophageal, subcarinal, perigastric , gastric artery region and celiac nodes • McKeown(3 field esophagectomy) -right thoracotomy , upper midline laparotomy and left sided transverse neck incision • Transhiatal esophagectomy -upper midline laparotomy and left sided neck but has incomplete lymphadenectomy
  • 18.
    LYMPHADENECTOMY • 1 field–clear Lymph nodes in one area either cervical/thoracic/abdominal • 2-field-(thoracic +abdomen) • 3 field For squamous cell carcinoma-usually 3 field lymphadenectomy done (as it is more common in uppr and middle position of oesophagus) Adenocarcinoma-usually 2 field lymphadenectomy (more common in lower esophagus)
  • 19.
    • Neoadjuvant therapy -withpreoperative chemotherapy/chemoradiotherapy-enhance local control and resectibility • Radiotherapy For attempted cure and palliation of SCC oesophageal carcinoma-if not suitable for resection • Palliative treatment-to relieve obstruction/mitigate dysphagia a)Radiotherapy and chemotherapy-adenocarcinoma less responsive b)Intraluminal prostheses-rigid tube/expanding stents -Potential complication: perforation , erosion migration of the stent/obstruction c)Endoscopic laser technique
  • 20.